Calvin Horry
Analyst (Horry Capital)
Replay available
Entera Bio Ltd. (ENTX) Q1 2021 Earnings Call
Entera Bio Ltd. (NASDAQ: ENTX) Q1 2021 earnings conference call, held 2021-05-20. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Spiro Jamas
Chief Executive Officer
Art Santora
Chief Medical Officer
Jason McCarthy
Analyst (Maxon Group)
John Lieber
Chief Financial Officer
Philip Schwartz
President of R&D
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Entera Bio Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.009 -- 00:00:03.731 Good morning and welcome to Interra's BIOS conference call to discuss the financial and 00:00:03.731 -- 00:00:07.373 operating results for the year ended December 31st, 2020. 00:00:07.373 -- 00:00:10.155 At this time, all participants are in a listen-only mode. 00:00:10.155 -- 00:00:13.237 After the speaker's presentation, there'll be a question and answer session. 00:00:13.237 -- 00:00:16.799 To ask a question during the session, you'll need to press star one on your telephone. 00:00:16.799 -- 00:00:20.041 If you require any further assistance, please press star then zero. 00:00:20.041 -- 00:00:23.503 I would now like to turn the call over to John Lieber, the US-based CFO of Interra. 00:00:23.503 -- 00:00:25.923 Please go ahead. 00:00:32.912 -- 00:00:38.215 Thank you, and welcome to the call. Joining me on today's call are Spiro Jamas, 00:00:38.215 -- 00:00:39.895 our CEO, 00:00:39.895 -- 00:00:44.358 Art Santora, our CMO, and Philip Schwartz, our President of R&D. 00:00:44.358 -- 00:00:47.799 A press release announcing Interra's financial and operating results for the year-end 00:00:47.799 -- 00:00:49.460 of December 31, 2020, 00:00:49.460 -- 00:00:53.762 was issued earlier today. For those of you who have not yet seen it, it is available 00:00:53.762 -- 00:00:58.484 on the Investor section of our website, www.interrabio.com. 00:00:59.631 -- 00:01:02.733 On our call this morning, we will share with you a business update and review of our 00:01:02.733 -- 00:01:07.197 financial results, which will be followed by a question and answer session. 00:01:07.197 -- 00:01:10.740 Before we begin our prepared remarks, I would like to remind you that various statements 00:01:10.740 -- 00:01:15.343 we make during this call about the company's ...